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ABSTRACT
Caffeine consumption during pregnancy has been shown in the scientific literature to 
be associated with teratogenicity such as low birth weight, fetal malformations, and 
miscarriage. However, the morphological alterations of the offspring of dams exposed 
during pregnancy have not been consistently described, and the mechanisms why 
they occur remain elusive. Thus, we aimed to characterize the offspring malformations 
induced by moderate and high doses of caffeine during pregnancy. Dams were divided 
into three groups: control, moderate (0.3 g/L), and high dose (1.0 g/L) of caffeine, 
which was provided in the drinking water beginning on gestational day 1 and continuing 
throughout the entire gestation. At moderate doses, only one of the dams had stillborn 
pups, although no macroscopic malformations were observed. High doses of caffeine 
induced significantly more malformations (P<0.001) and early death (before P4). 
The malformations observed were related to fetal development and cardiovascular 
alterations, namely bruises, macrocephaly with short limbs, abnormal development 
(or absence) of head structures and limbs, labial malformations, hydrops fetalis, and 
poor placental formation. We discussed the proposed mechanisms by which caffeine 
might induce these phenotypes, which may involve down-regulation of adenosine 
A1 receptors, and increased mothers’ catecholamines. Our findings further confirm 
the evidence of the teratogenic effects of high doses of caffeine administered during 
pregnancy. These findings support the recommendation to avoid caffeine exposure 
during pregnancy.
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Different foods contain variable quantities of caffeine, including tea, coffee, 
soda, energy drinks, chocolate and analgesic formulations1,2. When consumed 
during pregnancy, caffeine might increase the risk for miscarriage3, stillbirth4, 
fetal growth restriction5, and low birth weight6. Thus, regulatory agencies 
worldwide recommend pregnant women against consuming more than 
200-300 mg/day of caffeine (FDA, FSA and WHO), which is equivalent to a 
“moderate dose” of coffee or two espressos per day. Together, two espressos 
(around 44-60 mL) contain around 200 mg of caffeine. Nevertheless, consuming 
more than two espressos per day or its equivalent is not uncommon and neither 
is consuming foods containing even higher doses of caffeine (i.e. 600 mg of 
caffeine per day)7.
Determining a safety window for caffeine consumption during pregnancy 
is difficult. Although epidemiological studies have found correlation of caffeine 
with birth defects only with doses above 600 mg per day7, experimental studies 
in animals have confirmed that lower caffeine doses, around 30 mg/kg/day by 
mouth, which is considered moderate8, can predispose offspring to seizures9, 
altered locomotive activity10, increased emotional reactivity, impulsivity11, and 
impaired cognitive functioning12. The oral consumption of caffeine doses 
higher than 60mg/kg/day might even induce spontaneous abortion13, low 
birth weight6,14, intrauterine growth retardation5, and induce teratogenicity15. 
Furthermore, the detailed description of the types of malformations induced 
by caffeine consumption during pregnancy remains elusive.
When facing such ambiguity, it is a challenge to convince the pregnant 
population to avoid caffeine consumption. Defining whether morphological 
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malformations might be associated to moderate or to 
high doses of caffeine and improving the description 
and understanding of the alterations induced during 
fetal development, might help sensitize patients 
and caregivers against consumption of products 
with caffeine during pregnancy. Thus, we aimed to 
further characterize the malformations induced by 
moderate and high caffeine intake during pregnancy, 
and discuss the possible mechanisms involved.
METHODS
Animals
Adult female Wistar rats (weighting approximately 
220 g), 90 days old were submitted to vaginal lavage 
to verify the estrous cycle. In their fertile phase, 
females were housed in the evening with a fertile 
male. The following morning, males were removed 
and the vaginal smears were collected. Mating was 
confirmed by sperm presence in vaginal smears. 
The day of sperm detection in the vaginal smears was 
considered as day 0 (G0). All animals were housed 
individually in cages made of polypropylene material 
(49 × 34 × 16 cm) of laboratory-grade and were 
maintained in a standard 12:12 hour light/dark cycle 
(lights on at 07:00 a.m. and lights off at 07:00 p.m.) 
in a controlled environment (22±2 °C). Animals had 
access to water or caffeinated water, and chow 
ad libitum. The experiments and procedures were 
approved by the Institutional Committee for Animal 
Care and Use (GPPG-Hospital de Clínicas de Porto 
Alegre protocol N. 110034) and conformed to the 
Laboratory Guide for the Care and Use of Animals 
(The National Academies Press, Eighth Edition, 2011). 
Animal handling and all experiments were performed 
in accordance with international guidelines for animal 
welfare and measures were taken to minimize animal 
pain and discomfort.
Interventions
The dams were divided into three groups (n = 9 
per group) according to the intervention administered, 
namely (1) Control group, which received only tap 
water; (2) moderate caffeine consumption, which 
received 0.3 g/L of caffeine (Sigma Chemical Co; 
St. Louis, MO, USA) dissolved in tap water; and 
(3) high caffeine consumption, which received 
1.0 g/L of caffeine dissolved in tap water. Caffeine 
was provided in the drinking water from the first 
gestational day, and continued during the entire 
gestational period (21 days).
Assessments
Water consumption was measured every other 
day for each dam, starting on the first gestational day 
(G1). Photographical registry and description of the 
litter was performed immediately after birth. However, 
to avoid mothers’ stress and possible rejection of the 
litter due to human manipulation, pups were only 
weighed on the second postnatal day.
Statistical Analysis
Variables were summarized using conventional 
descriptive statistics. Birth-weight and water 
consumption were compared between groups using 
one-way Analysis of Variance (ANOVA). To determine 
the association of caffeine with the presence of 
malformations, the Fisher’s exact test was used. 
Statistical significance was set to a P value of 0.05. 
The data were analyzed using SPSS version 18.0 
(SPSS, Chicago, IL).
RESULTS
A total of 27 female rats were used in the experiment, 
and each dam delivered between 5-14 pups.
Dams Water Consumption
The water intake did not differ significantly between 
dams (one-way ANOVA, P>0.05). Controls drank 
43.8±12.67 (mean±SD) mL/day, the moderate dose 
group, 47.4±9.54 mL/day (approximately 142.2 mg 
of caffeine per day), and the high dose group drank 
49.0±10.32 mL/day (490.0 mg of caffeine per day).
Control Group (n=9 dams) Offspring 
Observations
The dams that received water and standard food 
conceived normal term litter (21 gestational days) 
(figure 1). Each dam conceived 10-14 pups.
Moderate Dose of Caffeine (0.3 g/L) (n=9 dams) 
Offspring
One of the dams (14%) that received water with 
caffeine at 0.3 g/L, had only stillborn pups (n=8), 
with no visible malformations. The rest of the dams 
conceived normal offspring, each with 8-12 pups.
High Dose of Caffeine (1 g/L) (n=9 dams) 
Offspring
No preterm births were observed, but there were 
two dams (23%) that had only stillborn pups (6-8) 
without visible malformations. Two of the dams 
(23%) had their whole litter with some degree of 
malformation: In the litter of the first dam (6 pups), 
it was observed bruises on the body (figure 2a and 
figure 2b), macrocephaly with short limbs (figure 2c 
and figure d), abnormal development (or absence) 
of head structures (i.e. mouth, ears, eyes) and limbs 
(figure 2e), labial malformations (figure 2e) and 
hydrops fetalis (figure 2f). In the litter of the second 
dam, although all the products of gestation were at 
term (8 pups), severe malformations were observed 
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(figure 3), including poor placental formation, limbs 
absence and abnormal development (or absence) of 
head structures (i.e. mouth, ears, eyes). The litter of 
a third dam (11%) had no evidence of malformations. 
Nevertheless, the whole third litter was victim of 
cannibalistic behavior by the mother. Although the 
other three litters (43%) did not have evidence of 
malformations, 80% of the offspring spontaneously died 
between P1 and P4. Each dam conceived 6-9 pups 
and had 21 days of gestation. The final 2 litters 
Figure 1: Appearance of a normal litter (control group). Part a presents the appearance of a normal litter at the first 
postnatal day. Part b presents its appearance at the third postnatal day. Notice the proportion of the head, limbs, and 
presence of lanugo hair.
Figure 2: Malformations in the first dam of rats exposed to a sustained high dose of caffeine (1 g/L). The picture presents 
the bruises (a and b), macrocephaly with short limbs (c and d), abnormal development (or absence) of head structures 
(i.e. mouth, ears, eyes) and limbs (e), and hydrops fetalis (f).
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(23%) that had confirmed pregnancy (through sperm 
presence in vaginal smears and weigh gain) did not 
give birth. We inferred that the rats had spontaneous 
abortions early in the pregnancy, because no evidence 
of birth neither of cannibalism was observed. There 
were significantly more malformations in the litter of 
dams that received a high dose of caffeine during 
pregnancy, while the presence of malformations in 
the litters from dams exposed to moderate caffeine 
doses were not significantly different from controls 
(Fisher’s exact test, P<0.001, see table 1).
Birth Weight
The offspring of the dam exposed to moderate 
dose of caffeine had significantly lower birth weight. 
At birth, the control group litter mean weight was 
7.11±0.49 g, while the moderate dose of caffeine litter 
weighted 6.64±0.54 g (t=-2.237, P=0.031). None of 
the rats with malformations were weighted, because 
malformations occurred in both senses inducing high 
variability: some of the rats were extremely small 
at birth (figure 3g) while some malformations were 
associated to an increase in body size (figure 2d).
DISCUSSION
Our experiment describes the characteristics 
of the teratogenicity induced by exposure to high 
doses of caffeine during pregnancy in rats. Moderate 
doses of caffeine (142.2 mg per day), did not induce 
a significant number of malformations, while a high 
dose (490.0 mg of caffeine per day) induced significant 
Table 1: Tabulation of the presence of malformations in the dams according to the intervention. The dams exposed to 
high doses of caffeine presented litter with significantly more malformations, while litters of those exposed to a moderate 
dose did not differ from controls.
Number of dams with malformations TotalControl Moderate dose High dose
Any malformation
Yes 0a 1a 9b 10
No 9a 8a 0b 17
Total 9 9 9 27
Shared letter denotes categories whose column proportions do not differ significantly from each other at the 0.05 level.
Figure 3: Spectrum of malformations in the offspring of rats exposed to a sustained high dose of caffeine (1 g/L). 
The picture presents the spectrum of malformations induced, from absence of structures differentiation, going through 
short head and limbs.
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teratogenicity, manifesting as malformations of the 
cardiovascular and renal system including petechiae, 
hematomas (sign of capillary fragility), and hydrops 
fetalis (“swollen appearance”; accumulation of 
fluids). Our findings are in agreement with other 
studies evaluating exposure to caffeine during fetal 
development, which have described malformations of 
the cardiovascular system16-18. Different mechanisms 
addressing the teratogenic effects of caffeine have 
been proposed, including down-regulation of adenosine 
receptors, induction of catecholamine release, 
phosphodiesterase inhibition, and mutagenic role 
due to its similarity with purine components.
When chronically administered to pregnant rats, 
caffeine is capable of down-regulating adenosine 
A1 receptors, and this decrease can cause changes 
in the formation of fetal cardiovascular tissues16. 
Adenosine plays a key role in protecting the embryo 
against intrauterine stress such as hypoxia; particularly 
through A1 receptors expressed in the heart19, and 
it has potent effects (in vitro and in vivo) on the 
cardiovascular system of different species20,21. During 
embryogenesis, adenosine A1 receptors are the dominant 
regulator of embryonic heart rate. On the other hand, 
caffeine can alter the embryonic cardiac function, 
disrupting the cardiac response to hypoxia through 
blockade of adenosine action on the A1 receptors18. 
Thus, caffeine-induced down-regulation of adenosine 
A1 receptors is one of the plausible mechanisms 
supporting the cardiovascular teratogenicity observed 
in our study.
Other pathophysiological mechanisms of 
caffeine might have been related to the observed 
malformations. Caffeine decreases the blood supply 
in the placenta22, which promotes reduction of fetal 
osmotic plasma pressure and increments in capillary 
permeability due to the abnormal transportation of 
water in intracellular and extravascular tissues23. 
Supporting this hypothesis, it has been demonstrated 
that caffeine teratogenic effects might occur by virtue 
of catecholamine release from maternal adrenal 
glands or embryonic tissues24-26. Mineralocorticoids 
favor liquid retention through sodium uptake, loss 
of potassium, and vasoconstriction of placental 
arterioles, which prejudices nutrients exchange 
and favors maternal and fetal hypertension27. 
In turn, the insufficient blood flow to the placenta 
after exposure to caffeine leads to fetal hypoxia, 
followed by intrauterine growth retardation or uterine 
vasoconstriction maintained by catecholamines28. 
Tofovic and colleagues29 demonstrated that caffeine 
augments renin release sympathetically mediating 
increased sympathetic tone, supporting the fact 
that caffeine increases renin secretion under basal 
conditions and in response to various stimuli by 
blocking intrarenal adenosine receptors. A recent 
study using 20 mg/kg of caffeine subcutaneously 
in mice (which corresponds to two cups of coffee 
in humans), revealed that chronic administration of 
caffeine to pregnant dams led to persistent activation 
of local renin-angiotensin system in the kidney and 
heart of the offspring, which in turn, led to high blood 
pressure and adverse cardiac remodeling30. Taken 
together, the observations of the effects of caffeine 
on the cardiovascular and renal systems provide a 
sound explanation of the fluid balance alteration that 
can lead to the macroscopic malformations presented 
in our report (i.e. hydrops fetalis, bruises, petechiae or 
hematomas). The increase of catecholamines in the 
mother can also be related to miscarriage, stillborn 
offspring, and changes in mother’s and offspring’s 
behavior and motor development31. In addition, we 
observed that one litter had an incomplete fetal 
development (figure 3). This might also be related 
to the elevation in maternal glucocorticoids, and to 
the metabonome alterations that prenatal exposure 
to caffeine can induce, as relevant discriminatory 
metabolites might be involved in the metabolic 
programming of caffeine-induced intrauterine growth 
retardation5.
At high concentrations, caffeine may also 
have a direct effect on γ-aminobutyric acid type A 
(GABAA)
32,33, which could have affected rat behavior. 
Such neuronal and behavioral changes could explain 
the cannibalistic behavior observed in some of the 
dams. Although these dams had an apparently 
normal litter as assessed on the first postnatal day, 
by the second day the pups were not found. As our 
assessments occurred in the morning and in the 
evening, we can infer that cannibalistic behavior 
occurred at night, according to the species nocturnal 
habit. When animals of this species face litters with 
some degree of deformity or when under stress, the 
mother presents cannibalistic behavior, even at term34. 
The characteristics of our experiment do not allow 
us to determine whether cannibalism occurred due 
to the probable dam behavioral alterations induced 
by caffeine or due to malformations of the litter.
High doses of caffeine also induced other 
significant malformations in the limbs and head. 
Other authors have described caffeine-induced 
malformations of the limbs and digits (including 
ectrodactyly), craniofacial malformations (labial and 
palatal clefts)35,36, and delays in ossification of limbs, 
jaw and sternum37,38. In our study, we observed few 
labial malformations in comparison to literature 
reports. Such difference might have occurred due to 
variations in the experimental models employed, as 
other authors have used different routes of caffeine 
administration (e.g. intraperitoneal, gavage37), and 
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have combined it with other drugs (e.g. nicotine39). 
Overall, craniofacial and limb malformations induced 
by caffeine have been attributed to a reduction in 
the number of branchial bars and somites, as well 
as an impairment in the formation of the forelimb, 
which occurs on the early morphogenesis of these 
regions35. Even moderate doses of caffeine are capable 
of inhibiting the phosphodiesterase enzyme that 
degrades cyclic adenosine monophosphate (cAMP), 
increasing the cAMP levels which may interfere on 
growth and development in fetal cells40,41.
The mutagenic potential of caffeine can also be 
related to its chemical similarity to purine components. 
Caffeine decreases the activity of deoxyribonucleic acid 
polymerase and the replication of deoxyribonucleic acid. 
It also increases the cyclic adenosine monophosphate, 
and cyclic guanosine monophosphate15,42. Thus, the 
incorporation of caffeine into the genetic material alters 
the instructions of cellular replication43, decreasing 
the mitosis G2 phase, and consequently the time to 
repair the chromosomal damage, ultimately increasing 
the percentage of dead cells44.
Applying this animal data to humans should be done 
with caution, as it deserves relevant considerations. 
The principal caffeine metabolism occurs via the 
cytochrome P450, enzyme 1A2 gene (CYP1A2), 
which is absent in the human placenta and fetus45,46. 
Therefore, the caffeine half-life in humans is increased 
in fetus and neonates, who cannot metabolize it 
until approximately 3 months of age47. During the 
first trimester, the half-life is greatly increased 5-6 h, 
whereas it increases up to 8-9 h between 12 and 
20 weeks gestation. Regarding the teratogenicity 
in humans, the organogenesis period is recognized 
as the most important, which limits the extrapolation 
from findings in rats because in this species the 
post-organogenesis period occurs in the third quarter 
after birth48. Furthermore, rats’ neural growth occurs 
in postnatal life, having that the first 7-10 postnatal 
days of a rat represent the third trimester of human 
pregnancy. Also, epidemiological studies indicate that 
human malformations are only positively associated 
with high caffeine consumption (600 mg) daily5, which 
is challenging to compare to doses in rats because 
of their metabolic differences49.
Our findings extend the evidence of the teratogenic 
effects due to high-dose caffeine consumption during 
pregnancy. Our description of the malformations induced 
by caffeine support their possible association with 
changes in the cardiovascular and renal physiology in 
both the mother and the fetus. These findings support 
the recommendation to avoid exposure of caffeine 
during pregnancy. The exact mechanism by which 
these teratogenic effects may occur has not been 
fully elucidated. Thus, further research addressing 
the integration of the mechanisms discussed, their 
effect on the cardiovascular and renal physiology, 
and their dosage translation to humans should be 
performed.
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